Assessing Youth Risk Behavior in a Clinical Trial Setting: Lessons From the Infant Health and Development Program
Abstract
Purpose
The purpose of this article was to describe the use of the Youth Risk Behavior Surveillance System (YRBSS) with known 17–18-year-old patients in follow-up of a multisite randomized clinical trial, and to develop a new scoring algorithm indicating the degree of risk-taking behavior for between-group analyses.
Methods
Seventy-five questions from the YRBSS were incorporated into the study questionnaire, with the development of safety plans to guide the disposition of participants. The YRBSS questions were grouped into two categories (with three subdomains each) named problem behaviors (conduct problems, sexual behavior, and suicide/hopelessness) and substance use (cigarettes, alcohol, and marijuana use), with scores for each subdomain indicating high, moderate, and low risk.
Results
Of the 677 participants, the safety plan was activated 215 times for 199 (29.4%) of participants. Risk behaviors included binge drinking (149), alcohol/substance use and driving (41), depression (22), hopelessness (37), and suicidal ideation (13; all in the past). No emergency room evaluations were required. The subdomain scaling was analyzed by demographic characteristics, and findings were consistent with the literature; for example, higher rates of conduct problems in males, more suicidal ideation in females, greater sexual risk in African Americans, more substance use in males and whites, and more alcohol use in youth with mothers with higher levels of education.
Conclusions
YRBSS can be administered in a research setting with appropriate safety precautions. These results should provide a useful guide to the application of the YRBSS to other adolescent populations in the future.
Keywords: Youth Risk Behavior Surveillance System, Adolescents, Safety plan, Suicidal ideation, Depression, Substance use, Risk behaviors
To access this article, please choose from the options below
Participating Sites in IHDP: University of Washington, Seattle, WA; University of Texas Southwestern Medical Center, Dallas, TX; University of Pennsylvania School of Medicine, Children's Hospital of Philadelphia, Philadelphia, PA; University of Miami School of Medicine, Miami, FL; Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, MA; Children's Hospital Boston, Boston, MA; University of Arkansas for Medical Sciences, Little Rock, AR. For a complete list of participants, please see reference 18.
PII: S1054-139X(09)00599-0
doi:10.1016/j.jadohealth.2009.10.010
© 2010 Society for Adolescent Medicine. Published by Elsevier Inc. All rights reserved.
